Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops

✍ Scribed by G. M. Lambert-Messerlian; D. N. Saller Jr.; M. B. Tumber; C. A. French; C. J. Peterson; J. A. Canick

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 157 KB
• Volume: 18
• Category: Article
• ISSN: 0197-3851
• DOI: 10.1002/(sici)1097-0223(199810)18:10<1061::aid-pd404>3.0.co;2-m

✦ Synopsis

The objective was to investigate whether cases of fetal trisomy 18 and Turner syndrome with and without hydrops were associated with alterations in the second-trimester levels of maternal serum inhibin A. Twenty-one cases of trisomy 18, 10 cases of Turner syndrome without hydrops and 12 cases of Turner syndrome with hydrops were identified. Five control samples were matched to each case for date of sample collection and completed week of gestation.

Inhibin A levels were modestly, but significantly reduced in cases of trisomy 18 (median=0•88 MoM) and Turner syndrome without hydrops (median=0•64 MoM). In contrast, inhibin A levels were markedly increased in cases of Turner syndrome with hydrops (median=3•91 MoM). These data for Turner syndrome are similar to those for human chorionic gonadotropin (hCG). The addition of inhibin A to multiple marker screening (alpha-fetoprotein, unconjugated oestriol and hCG) resulted in a median increase in the Down syndrome risk of 2•6-fold in cases of Turner syndrome with hydrops. The addition of inhibin A to multiple marker Down syndrome screening programmes will be likely to enhance the detection of fetal Turner syndrome with hydrops, but will not contribute substantially to the detection of fetal trisomy 18. 1998 John Wiley & Sons, Ltd.